NVIDIA Corporation (NVDA) — closed signal from March 17, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on June 15, 2026.
Predicted vs. what happened
NVDA price · publication thesis → realized outcomesplit-adjusted
$178.00 – $186.00Entry zone — fair-value band
$184.25Published — price the day we called it
$213.73Target — the price the thesis aimed for
$236.54Peak — highest point inside the window, not a realized return
$212.45Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 41 days.
Peak price
$236.54
peak on May 14, 2026 — not a realized returnPeak gain
+28.4%
peak, from the publication priceWindow close
$212.45
end-of-window price, context onlyDays to target
41
Window
March 17, 2026 – June 15, 2026
The thesis — published March 17, 2026
Predicted growth
+16%
over the measurement windowTarget price
$213.73
the price the thesis aimed forEntry zone
$178.00 – $186.00
the fair-value band we waited forPrice at publication
$184.25
published March 17, 2026Confidence
77%
how strongly the data lined upTimeframe
Short-term (0–3 months)
NVIDIA is kept under close observation because the company and its news are very strong, but many investors already own it so the stock can move sharply and may not fall much before rebounding. New enterprise programs and a bigger AI chip opportunity point to continued demand, so the plan is to buy gradually on pullbacks, not to chase fast gains.
Primary drivers
- Ongoing company news keeps AI demand momentum visible and credible
- More enterprise deployments show real customer adoption continuing
- Large scale and strong cash flow make the business unusually solid
- Many investors already own it, so prefer buying on weakness
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.